CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons

{{article.zuoZheEn}}

PDF(4412 KB)
PDF(4412 KB)
Life Medicine ›› 2022, Vol. 1 ›› Issue (1) : 27-44. DOI: 10.1093/lifemedi/lnac020
Article

CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Life Medicine, 2022, 1(1): 27‒44 https://doi.org/10.1093/lifemedi/lnac020

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(4412 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉